Medigate was an Israeli cybersecurity company founded in 2016 (or 2017, per some sources) that specialized in securing operational technology (OT) and Internet of Things (IoT) devices, particularly connected medical devices, within healthcare environments. The company provided comprehensive visibility, threat detection, and risk management solutions for medical networks, helping hospitals and healthcare providers protect connected medical devices from cyber threats. Founded by a team of experts in cybersecurity and healthcare IT, Medigate's platform utilized passive monitoring and deep packet inspection to map IoT assets, detect anomalies, and enforce security policies without disrupting clinical operations. Its technology addressed the unique challenges of healthcare IoT, including the vulnerability of legacy medical devices and compliance with regulations like HIPAA and GDPR. The company quickly gained traction, securing partnerships with major healthcare organizations and device manufacturers worldwide, with its solutions deployed in over 200 hospitals globally by the time of its acquisition. In 2021, Medigate was acquired by Claroty, a leading industrial cybersecurity company, in a deal reportedly valued at around $100 million, integrating its healthcare-focused expertise to expand Claroty's capabilities in the healthcare sector and enhance its broader platform for securing OT and IoT environments across industries. Post-acquisition, Medigate's technology continued to operate under the Claroty umbrella. The company was based in Tel Aviv and operated primarily in the B2B space, serving clients in North America, Europe, and Asia. Its leadership included CEO Benny Porat, who played a pivotal role in its development and the acquisition process. While Medigate itself had no major public controversies, the broader cybersecurity sector has faced scrutiny over data privacy and the effectiveness of IoT protections in critical infrastructure like healthcare.